[HTML][HTML] EBV and apoptosis: the viral master regulator of cell fate?
L Fitzsimmons, GL Kelly - Viruses, 2017 - mdpi.com
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - Viruses (1999-4915), 2017 - search.ebscohost.com
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are …
[PDF][PDF] EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - pdfs.semanticscholar.org
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
[HTML][HTML] EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - Viruses, 2017 - ncbi.nlm.nih.gov
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
EBV and Apoptosis:: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - Viruses, 2017 - research.birmingham.ac.uk
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are …
[PDF][PDF] EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - Viral Infection and Apoptosis - mdpi.com
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
[PDF][PDF] EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - researchgate.net
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
[PDF][PDF] EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - Viral Infection and Apoptosis - ndl.ethernet.edu.et
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - Viruses, 2017 - search.proquest.com
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are …
[PDF][PDF] EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
L Fitzsimmons, GL Kelly - minerva-access.unimelb.edu.au
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …